17,830 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Acquired by West Family Investments Inc.

West Family Investments Inc. bought a new stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 17,830 shares of the company’s stock, valued at approximately $254,000.

Several other hedge funds also recently bought and sold shares of the stock. SG Americas Securities LLC increased its position in Takeda Pharmaceutical by 5.4% during the 1st quarter. SG Americas Securities LLC now owns 16,099 shares of the company’s stock worth $224,000 after purchasing an additional 824 shares in the last quarter. Sei Investments Co. grew its holdings in shares of Takeda Pharmaceutical by 6.7% during the first quarter. Sei Investments Co. now owns 372,975 shares of the company’s stock worth $5,181,000 after buying an additional 23,525 shares in the last quarter. Russell Investments Group Ltd. raised its position in shares of Takeda Pharmaceutical by 65.2% in the first quarter. Russell Investments Group Ltd. now owns 10,676 shares of the company’s stock valued at $148,000 after buying an additional 4,213 shares during the last quarter. Blair William & Co. IL lifted its stake in shares of Takeda Pharmaceutical by 6.5% during the first quarter. Blair William & Co. IL now owns 12,649 shares of the company’s stock valued at $176,000 after buying an additional 777 shares during the period. Finally, O Shaughnessy Asset Management LLC boosted its position in Takeda Pharmaceutical by 43.2% during the first quarter. O Shaughnessy Asset Management LLC now owns 88,663 shares of the company’s stock worth $1,232,000 after acquiring an additional 26,735 shares during the last quarter. Hedge funds and other institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Stock Up 0.7 %

TAK stock opened at $13.62 on Wednesday. Takeda Pharmaceutical Company Limited has a one year low of $12.57 and a one year high of $15.08. The stock has a market capitalization of $43.34 billion, a P/E ratio of 23.48, a PEG ratio of 0.26 and a beta of 0.54. The company has a 50 day moving average price of $14.19 and a two-hundred day moving average price of $13.84. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.77 and a current ratio of 1.28.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.